Journal
/
/
Генерация CAR Т-клеток в усыновители терапии в контексте глиобластомы стандарт медицинской помощи
Journal JoVE
Immunologie et infection
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Immunologie et infection
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
DOI:

12:55 min

February 16, 2015

, , , , ,

Chapitres

  • 00:05Titre
  • 01:59Administration of Temozolomide and Whole Brain Irradiation to Tumor-bearing Mice (days 0-4)
  • 03:26Cell Transfection, Splenectomy, and T Cell Preparation (day 0)
  • 06:09Transduction (days 1 and 2)
  • 08:10CAR T Cell and Administration to Tumor-bearing Mice (days 3-5)
  • 10:03Results: Antitumor Efficacy of CAR T Cells
  • 11:47Conclusion

Summary

Traduction automatique

The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.

Vidéos Connexes

Read Article